Phase 4 Pancreatitis Trial, Recruiting (NCT06260878)

Phase 4 Pancreatitis Trial, Recruiting NCT06260878 Sponsor: University of Calgary Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT06260878 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old
You are able to understand and sign a consent form agreeing to take part
You have not had previous procedures that altered the opening where the bile duct meets the small intestine (confirm with trial site)
You are able and willing to have a blood test the day after your procedure (called an ERCP)

Who may not be able to join:

You have previously had a procedure that cut or widened the opening where the bile duct meets the small intestine
You have a confirmed or suspected serious bile duct infection or blood infection (sepsis)
You have been diagnosed with pancreatitis, or have had abnormal pancreas enzyme levels in the last 7 days
You have moderate or severe heart failure (confirm with trial site)
You currently have fluid build-up in your lungs
You have had a heart attack or reduced blood flow to the heart within the last 3 months
Your kidneys are not working well enough (confirm specific kidney function level with trial site)
You have significant liver scarring or end-stage liver disease (confirm with trial site)
Your blood oxygen level is below 90% while breathing normal air, or you use oxygen at home
Your blood sodium levels are too high or too low (confirm with trial site)
You have uncontrolled high or low blood pressure
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 403-880-8508

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06260878

Sponsor: University of Calgary

Phase: Phase 4

Status: Recruiting

Condition: Pancreatitis

Trial contact: 403-880-8508

More information: https://clinicaltrials.gov/study/NCT06260878

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old
You are able to understand and sign a consent form agreeing to take part
You have not had previous procedures that altered the opening where the bile duct meets the small intestine (confirm with trial site)
You are able and willing to have a blood test the day after your procedure (called an ERCP)

Who may not be able to join:

You have previously had a procedure that cut or widened the opening where the bile duct meets the small intestine
You have a confirmed or suspected serious bile duct infection or blood infection (sepsis)
You have been diagnosed with pancreatitis, or have had abnormal pancreas enzyme levels in the last 7 days
You have moderate or severe heart failure (confirm with trial site)
You currently have fluid build-up in your lungs
You have had a heart attack or reduced blood flow to the heart within the last 3 months
Your kidneys are not working well enough (confirm specific kidney function level with trial site)
You have significant liver scarring or end-stage liver disease (confirm with trial site)
Your blood oxygen level is below 90% while breathing normal air, or you use oxygen at home
Your blood sodium levels are too high or too low (confirm with trial site)
You have uncontrolled high or low blood pressure
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of Calgary

Registry

ClinicalTrials.gov

Start date

22 November 2024

Est. completion

30 June 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Serum amylase

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov